by Lance Roberts
My articles My offerMy siteAbout meMy videosMy books
Follow on:TwitterSeeking AlphaFacebookAmazon
| Regular portfolio check-ins are crucial! Evaluate sizing and impact of each position to avoid trouble. #investingtips #financialplanning Watch the entire show here: https://cstu.io/1f237a YouTube channel = @ TheRealInvestmentShow |
You Might Also Like
educing Stock Position: A Strategy for Managing Concentrated Holdings
2025-02-12
? Planning is key! Just like we plan for retirement and finances, having a strategy for reducing your stock position is crucial. #FinancialTips ?
Watch the entire show here: https://cstu.io/7ae172
YouTube channel = @ TheRealInvestmentShow
2-11-25 FOMO is Alive & Well
2025-02-11
Markets are coming to grips with that Trump Tariffs really mean, and are adapting through sector rotations. Lance & Jonathan discuss the prices of eggs & milk and grocery dates. The market defies more negative news because retail investors continue to step in and “buy the dip.” Retail sentiment is quite remarkable. Since the pandemic, retail investors have never been this bullish on the stock market. Such is amazing, given that their mailboxes are not being stuffed with government stimulus checks. Lance and Jonathan discuss FOMO investing trends from the stock market’s fear of missing out, a look at the best stocks for FOMO investors, and how to avoid investment FOMO; a look at market bubbles and investor psychology, and we also cover questions we didn’t get to on last Saturday’s Candid
Avoid Emotional Trading: Key to Better Long-Term Returns
2025-02-06
Emotional trading leads to mistakes & selling bottoms. Turn off, let the market digest. Don’t follow the herd. Timing is key. #StockMarketTips
Watch the entire show here: https://cstu.io/9193b9
YouTube channel = @ TheRealInvestmentShow
Lilly Tops Nordisk In Weightloss Battle
2024-12-05
The two market-leading weight loss/obesity drugs (GLP-1), Zepabound (Eli Lilly) and Wegovy (Novo Nordisk), just completed a clinical side-by-side trial. After 72 weeks of testing on 750 obese or overweight adults with at least one medical problem, Eli Lilly came out ahead by a substantial margin. Per Eli Lilly: Zepabound provided a 47% greater relative …
Leverage And Speculation Are At Extremes
2024-12-03
Financial markets often move in cycles where enthusiasm drives prices higher, sometimes far beyond what fundamentals justify. As discussed in last week’s #BullBearReport, leverage and speculation are at the heart of many such cycles. These two powerful forces support the amplification of gains during upswings but can accelerate losses in downturns. Today’s market environment shows …
Tags: Featured,newsletter
